FGF23 and enthesopathy: Indeed, transgenic mice overexpressing the secreted form of human FGF23 exhibit enthesopathy (72), and entheseal fibrochondrocytes are known to express the FGFR3 receptor as well as the Klotho coreceptor, which promotes FGF23 signaling (70).